BELOVAX
The "BELOVAX" trademark, serial number 77689480 , was filed on 12th of March 2009 with a mark drawing code of 4000 and its transaction date is 77689480. The attorney assigned is Maribeth Day Case, attorney docket number TMR\5057978\. Since 22nd of March 2012, the document can be found in the M70 law office in the publication and issue section. The employee responsible is BURNS, ELLEN FERRER and the date it was published for opposition on 06/30/2009. The status of this trademark was checked last on 09/06/2011.
The "BELOVAX" trademark, serial number 85731524 , was filed on 18th of September 2012 with a mark drawing code of 4000 and its transaction date is 85731524. The attorney assigned is Christopher M. Hanes, attorney docket number TMR\5087305\. Since 7th of February 2014, the document can be found in the L40 law office in the publication and issue section. The date when we last checked the status of this trademark was 02/07/2014.
The corresponded responsible for this trademark is CHRISTOPHER M. HANES, located at GLAXOSMITHKLINE, 5 MOORE DR, RESEARCH TRIANGLE PARK, NC 27709-0183.The state or country where the trademark was organized is by Glaxo Group Limited. The legal entity type behing it is a Corporation, located at 980 Great West Road, Brentford, Middlesex, zip TW89GS.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 09/21/2012 |
Primary Code | 005 |
Goods codes | |
GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
02/07/2014 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
07/26/2013 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
07/24/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
03/20/2013 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | I - Incoming Correspondence | CHAN - APPLICANT CHANGES (NON-RESPONSIVE) ENTERED | |
03/20/2013 | TEAS CHANGE OF OWNER ADDRESS RECEIVED | I - Incoming Correspondence | COAR - TEAS CHANGE OF OWNER ADDRESS RECEIVED | |
01/22/2013 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS3 | |
01/22/2013 | LETTER OF SUSPENSION E-MAILED | F - First Action | GNSL - LETTER OF SUSPENSION E-MAILED | |
01/22/2013 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
01/15/2013 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
09/21/2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
09/21/2012 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.